Transcriptomics

Dataset Information

0

A synthetic mechanogenetic gene circuit for autonomous drug delivery in engineered tissues


ABSTRACT: Mechanobiologic signals play critical roles in regulating cellular responses under both physiologic and pathologic conditions. Using a combination of synthetic biology and tissue engineering, we developed a mechanically-responsive bioartificial tissue that responds to mechanical loading to produce a pre-programmed therapeutic biologic drug. By deconstructing the signaling networks induced by activation the mechanically-sensitive ion channel transient receptor potential vanilloid 4 (TRPV4), we synthesized synthetic TRPV4-responsive genetic circuits in chondrocytes. These cells were then engineered into living tissues that respond to mechanical compression to drive the production of the anti-inflammatory drug interleukin-1 receptor antagonist. Mechanical loading of these tissues in the presence of the cytokine interleukin-1 protected constructs from inflammatory degradation. This “mechanogenetic” approach enables long-term autonomous delivery of therapeutic compounds that is driven by physiologically-relevant mechanical loading with cell-scale mechanical force resolution. The development of synthetic mechanogenetic gene circuits provides a novel approach for the autonomous regulation of cell-based drug delivery systems.

ORGANISM(S): Sus scrofa

PROVIDER: GSE165027 | GEO | 2021/01/19

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA692990 | ENA
2024-06-05 | GSE269159 | GEO
2012-05-11 | E-GEOD-37944 | biostudies-arrayexpress
2024-09-02 | BIOMD0000000584 | BioModels
2022-07-27 | GSE203651 | GEO
2023-02-01 | GSE214582 | GEO
2013-11-21 | E-GEOD-50707 | biostudies-arrayexpress
2012-05-12 | GSE37944 | GEO
2013-11-21 | GSE50707 | GEO
2015-12-14 | E-GEOD-73889 | biostudies-arrayexpress